89bio Inc Stock Operating Margin
| ETNBDelisted Stock | USD 14.84 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess 89bio's long-term financial health and intrinsic value.
89bio |
89bio Inc Company Operating Margin Analysis
89bio's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, 89bio Inc has an Operating Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
89bio Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 89bio's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 89bio could also be used in its relative valuation, which is a method of valuing 89bio by comparing valuation metrics of similar companies.89bio is currently under evaluation in operating margin category among its peers.
89bio Fundamentals
| Return On Equity | -0.87 | |||
| Return On Asset | -0.49 | |||
| Current Valuation | 1.68 B | |||
| Shares Outstanding | 148.49 M | |||
| Shares Owned By Insiders | 0.59 % | |||
| Shares Owned By Institutions | 99.41 % | |||
| Number Of Shares Shorted | 6.77 M | |||
| Price To Earning | (1.04) X | |||
| Price To Book | 4.22 X | |||
| EBITDA | (384.66 M) | |||
| Net Income | (367.08 M) | |||
| Cash And Equivalents | 193.34 M | |||
| Cash Per Share | 4.16 X | |||
| Total Debt | 37.55 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 5.81 X | |||
| Book Value Per Share | 3.52 X | |||
| Cash Flow From Operations | (367.82 M) | |||
| Short Ratio | 0.74 X | |||
| Earnings Per Share | (3.69) X | |||
| Price To Earnings To Growth | (0.45) X | |||
| Target Price | 30.38 | |||
| Number Of Employees | 93 | |||
| Beta | 1.26 | |||
| Market Capitalization | 2.2 B | |||
| Total Asset | 478.69 M | |||
| Retained Earnings | (824.51 M) | |||
| Working Capital | 440.32 M | |||
| Current Asset | 10.12 M | |||
| Current Liabilities | 3.89 M | |||
| Net Asset | 478.69 M |
About 89bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 89bio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 89bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 89bio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in 89bio Stock
If you are still planning to invest in 89bio Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 89bio's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |